Related Experiment Video
Updated: Aug 10, 2026

04:14
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
Published on: April 16, 2019
Tamoxifen-associated steatohepatitis--report of three cases
H C Pinto1, A Baptista, M E Camilo
1Department of Medicine, University Hospital Santa Maria, Lisbon, Portugal.
Journal of Hepatology
|July 1, 1995
Abstract:
The authors describe three cases of tamoxifen-associated steatohepatitis, which resulted from a daily dosage of 20 mg used as the adjuvant treatment of breast carcinoma. Liver tests became normal after discontinuation of tamoxifen.

